Skip to content
healthcare.dev

tizanidine

NDC 80425-0454, tizanidine, tablet, from Advanced Rx of Tennessee, LLC.

Product NDC
80425-0454
Status
Listed
Labeler
Advanced Rx of Tennessee, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208187
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/80425-0454 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIZANIDINE HYDROCHLORIDE4 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
80425-0454-18042504540130 TABLET in 1 BOTTLE (80425-0454-1)
80425-0454-28042504540260 TABLET in 1 BOTTLE (80425-0454-2)
80425-0454-38042504540390 TABLET in 1 BOTTLE (80425-0454-3)
80425-0454-480425045404120 TABLET in 1 BOTTLE (80425-0454-4)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2788942d-87fa-e514-e063-6294a90a0971

Use it

Look up 80425-0454 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/80425-0454 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 80425-0454. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.